Higher proliferative response in B-chronic lymphocytic leukemia (B-CLL) as compared to B-monoclonal lymphocytosis of undetermined significance (B-MLUS) after stimulation with Staphylococcus aureus and anti-CD40 monoclonal antibodies-Reference-Cited by-同舟云学术

Higher proliferative response in B-chronic lymphocytic leukemia (B-CLL) as compared to B-monoclonal lymphocytosis of undetermined significance (B-MLUS) after stimulation with Staphylococcus aureus and anti-CD40 monoclonal antibodies

Published:1993-11 Issue:11 Volume:17 Page:933-939
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Garcia Carlos A.,Rosén Anders,Aguilar-Santelises Miguel,Jondal Mikael,Mellstedt Håkan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference53 articles.

1. Chronic lymphocytic leukemia;Gale,1985

2. Chronic lymphocytic leukemia cells activated in vitro reveal cellular changes that characterize B-lymphocytic leukemia and immunocytoma;Robért;Scand. J. Immun.,1983

3. Phorbol ester and B-cell stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous Ig secretion and DNA synthesis;Carlsson;Leukemia,1988

4. Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings;Gordon;Blood,1983

5. Two surface antigens, CD23 (p45) and a novel p50 molecule, deliver distinct progression signals to activated B-lymphocytes;Gordon,1987

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Indicators in CLL: Clinical, Cytogenetics, Novel Mutations, MicroRNAs, Hierarchal Classification;Molecular and Translational Medicine;2018

2. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis;Leukemia & Lymphoma;2007-01

3. Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5− CLL;Leukemia Research;2002-12

4. CD5-negative phenotype of monoclonal B-lymphocytosis of undetermined significance (MLUS);American Journal of Hematology;2002-01-18

5. Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival;Journal of Molecular Medicine;1999-01-18